Table 3.
Symptoms and physiological conditions of COPD patients with and without bronchiectasis
| Parameters | Patients without CT-detected bronchiectasis (N=38) | Patients with CT-detected bronchiectasis (N=34) | p-value |
|---|---|---|---|
| Age (years)a | 75.0 (69.0–79.5) | 71.0 (63.0–78.0) | 0.14 |
| Post-bronchodilator FEV1% predicteda | 59.50 (44.50–77.0) | 60.0 (46.0–75.25) | 0.91 |
| CAT scorea | 13.0 (3–37) | 13.0 (2–32) | 0.49 |
| mMRC scalea | 1.0 (0–4) | 1.0 (0–4) | 0.22 |
| COPD exacerbations ≥2 years or hospitalizations ≥1 year n (%) | 11 (37.93%) | 18 (62.07%) | 0.038 |
Notes:
a
Median and IQR. Data are presented as median, IQR and proportion (%). The statistical significance was determined by p-value <0.05.
Abbreviations: CAT, COPD assessment test; FEV1, forced expiratory volume in 1 second; CT, computed tomography; IQR, interquartile range; mMRC, modified Medical Research Council Dyspnea Scale.